Skip to Content
Find More Like This
Return to Search

Anticancer therapy

United States Patent Application

20070025910
A1
View the Complete Application at the US Patent & Trademark Office
A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.
Norenberg, Jeffrey P. (Albuquerque, NM)
11/ 493,063
July 26, 2006
GOVERNMENT FUNDING [0002] The invention was made with government support under Grant No. DE-FG01-001NE23554, awarded by the United States Department of Energy, and Grant No. DHHS/PHS/NIH/NCRR/GCRC, MO1 RR00997, awarded by the National Institutes of Health National Center for Research Resources. The U.S. Government has certain rights in this invention.